Hyperbaric oxygen therapy for ulcerative colitis flare
Part of Digestive system clinical trials.
This trial tests if hyperbaric oxygen therapy (breathing pure oxygen in a special chamber) can help people hospitalized with a moderate to severe ulcerative colitis flare get better faster. You will receive the therapy along with standard steroid treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 85 years old
- You have ulcerative colitis and are in the hospital for a moderate to severe flare
- You can start your first hyperbaric oxygen session within 48 hours of starting IV steroids
- You have not had hyperbaric oxygen therapy before
- You are not pregnant or nursing
- You do not have Crohn's disease or other forms of colitis
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether adding hyperbaric oxygen therapy—breathing pure oxygen in a pressurized chamber—to standard care can help people with a severe flare of ulcerative colitis (a type of inflammatory bowel disease). It may reduce inflammation and speed up recovery.
This trial gives hyperbaric oxygen treatment to patients with conditions where it's not yet standard. It studies if the therapy can help people with emerging medical issues.
This trial tests new therapies for people with a severe UC flare that hasn't improved after 5 days of high-dose steroids. It aims to find more effective options to control symptoms and avoid hospitalization.
This trial tests if low-intensity ultrasound waves applied to the colon can reduce inflammation in people with active ulcerative colitis. If successful, it could offer a new drug-free way to manage flare-ups.
This trial uses a gentle ultrasound scan (on the outside of the body) to see how well treatment is working during a moderate to severe flare of ulcerative colitis. It aims to find out if this painless test can predict recovery and help guide care without needing a telescope exam (endoscopy).
This study tests a new medication called BI 3032950 for people with ulcerative colitis who have already tried other advanced treatments (biologics or targeted therapies) that didn't work well enough or caused problems. The goal is to see if the new drug is safe and helps control inflammation in the colon.
Hear when a new Ulcerative Colitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.